PA
NBIX icon

Perceptive Advisors’s Neurocrine Biosciences NBIX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$32.1M Buy
255,050
+155,000
+155% +$19.5M 1.19% 23
2025
Q1
$11.1M Hold
100,050
0.39% 48
2024
Q4
$13.7M Sell
100,050
-112,178
-53% -$15.3M 0.38% 50
2024
Q3
$24.5M Sell
212,228
-437,681
-67% -$50.4M 0.52% 49
2024
Q2
$89.5M Sell
649,909
-154,500
-19% -$21.3M 2.16% 11
2024
Q1
$111M Buy
804,409
+533,615
+197% +$73.6M 1.94% 15
2023
Q4
$35.7M Buy
270,794
+111,552
+70% +$14.7M 0.8% 39
2023
Q3
$17.9M Buy
159,242
+59,192
+59% +$6.66M 0.6% 46
2023
Q2
$9.43M Hold
100,050
0.27% 66
2023
Q1
$10.1M Hold
100,050
0.3% 66
2022
Q4
$11.9M Hold
100,050
0.34% 57
2022
Q3
$10.6M Sell
100,050
-297,838
-75% -$31.6M 0.31% 64
2022
Q2
$38.8M Buy
397,888
+2,249
+0.6% +$219K 1.21% 22
2022
Q1
$37.1M Sell
395,639
-87,368
-18% -$8.19M 0.74% 36
2021
Q4
$41.1M Hold
483,007
0.63% 41
2021
Q3
$46.3M Sell
483,007
-328,825
-41% -$31.5M 0.67% 37
2021
Q2
$79M Sell
811,832
-130,000
-14% -$12.7M 1.03% 27
2021
Q1
$91.6M Sell
941,832
-957,383
-50% -$93.1M 1.16% 22
2020
Q4
$182M Buy
1,899,215
+350,500
+23% +$33.6M 1.95% 12
2020
Q3
$149M Sell
1,548,715
-592,695
-28% -$57M 2.17% 14
2020
Q2
$261M Sell
2,141,410
-921,853
-30% -$112M 4.23% 6
2020
Q1
$265M Sell
3,063,263
-549,291
-15% -$47.5M 6.91% 3
2019
Q4
$388M Sell
3,612,554
-447,346
-11% -$48.1M 7.71% 3
2019
Q3
$366M Buy
4,059,900
+36,038
+0.9% +$3.25M 9.86% 1
2019
Q2
$340M Buy
4,023,862
+265,200
+7% +$22.4M 7.8% 1
2019
Q1
$331M Sell
3,758,662
-849,892
-18% -$74.9M 9.34% 1
2018
Q4
$315M Sell
4,608,554
-168,700
-4% -$11.5M 12% 1
2018
Q3
$587M Buy
4,777,254
+62,004
+1% +$7.62M 15.71% 1
2018
Q2
$463M Sell
4,715,250
-46,739
-1% -$4.59M 12.14% 1
2018
Q1
$395M Sell
4,761,989
-389,600
-8% -$32.3M 11.06% 1
2017
Q4
$400M Buy
5,151,589
+360,000
+8% +$27.9M 13.25% 1
2017
Q3
$294M Buy
4,791,589
+1,214,000
+34% +$74.4M 11.22% 1
2017
Q2
$165M Buy
3,577,589
+211,059
+6% +$9.71M 8.28% 2
2017
Q1
$146M Buy
3,366,530
+50,007
+2% +$2.17M 8.3% 1
2016
Q4
$128M Buy
3,316,523
+840,251
+34% +$32.5M 9.13% 1
2016
Q3
$125M Sell
2,476,272
-321,695
-11% -$16.3M 8.09% 2
2016
Q2
$127M Buy
2,797,967
+77,000
+3% +$3.5M 8.82% 1
2016
Q1
$108M Buy
2,720,967
+224,800
+9% +$8.89M 9.44% 2
2015
Q4
$141M Sell
2,496,167
-446,800
-15% -$25.3M 10.45% 2
2015
Q3
$117M Sell
2,942,967
-341,500
-10% -$13.6M 9.35% 2
2015
Q2
$157M Sell
3,284,467
-456,800
-12% -$21.8M 9.45% 2
2015
Q1
$149M Buy
3,741,267
+176,000
+5% +$6.99M 11.55% 2
2014
Q4
$79.6M Sell
3,565,267
-1,000,000
-22% -$22.3M 6.68% 2
2014
Q3
$71.5M Sell
4,565,267
-34,600
-0.8% -$542K 7.24% 2
2014
Q2
$68.3M Sell
4,599,867
-19,500
-0.4% -$289K 6.7% 2
2014
Q1
$74.4M Buy
4,619,367
+435,630
+10% +$7.01M 7.81% 2
2013
Q4
$39.1M Sell
4,183,737
-86,967
-2% -$812K 4.69% 6
2013
Q3
$48.3M Sell
4,270,704
-811,013
-16% -$9.18M 3.92% 8
2013
Q2
$68M Buy
+5,081,717
New +$68M 6.86% 3